BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 29289480)

  • 1. Chaperone effect of sulfated disaccharide from heparin on mutant iduronate-2-sulfatase in mucopolysaccharidosis type II.
    Hoshina H; Shimada Y; Higuchi T; Kobayashi H; Ida H; Ohashi T
    Mol Genet Metab; 2018 Feb; 123(2):118-122. PubMed ID: 29289480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral Gene Therapy for Mucopolysaccharidosis II with Tagged Iduronate 2-Sulfatase Prevents Life-Threatening Pathology in Peripheral Tissues But Fails to Correct Cartilage.
    Catalano F; Vlaar EC; Dammou Z; Katsavelis D; Huizer TF; Zundo G; Hoogeveen-Westerveld M; Oussoren E; van den Hout HJMP; Schaaf G; Pike-Overzet K; Staal FJT; van der Ploeg AT; Pijnappel WWMP
    Hum Gene Ther; 2024 Apr; 35(7-8):256-268. PubMed ID: 38085235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II.
    Hong J; Cheng YS; Yang S; Swaroop M; Xu M; Beers J; Zou J; Huang W; Marugan JJ; Cai X; Zheng W
    Exp Cell Res; 2022 Mar; 412(1):113007. PubMed ID: 34990619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of iduronate -2- sulfatase gene in Tunisian patients with mucopolysaccharidosis type II.
    Chkioua L; Khedhiri S; Ferchichi S; Tcheng R; Chahed H; Froissart R; Vianey-Saban C; Laradi S; Miled A
    Diagn Pathol; 2011 May; 6():42. PubMed ID: 21605424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion of Rabies Virus Glycoprotein or gh625 to Iduronate-2-Sulfatase for the Treatment of Mucopolysaccharidosis Type II.
    Wood SR; Chaudrhy A; Ellison S; Searle R; Burgod C; Tehseen G; Forte G; O'Leary C; Gleitz H; Liao A; Cook J; Holley R; Bigger BW
    Hum Gene Ther; 2024 Apr; 35(7-8):232-242. PubMed ID: 37212263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin Receptor-Targeted Iduronate-2-sulfatase Penetrates the Blood-Retinal Barrier and Improves Retinopathy in Mucopolysaccharidosis II Mice.
    Imakiire A; Morimoto H; Suzuki H; Masuda T; Yoden E; Inoue A; Morioka H; Konaka T; Mori A; Shirasaka R; Kato R; Hirato T; Sonoda H; Minami K
    Mol Pharm; 2023 Nov; 20(11):5901-5909. PubMed ID: 37860991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An empowered, clinically viable hematopoietic stem cell gene therapy for the treatment of multisystemic mucopolysaccharidosis type II.
    Das S; Rruga F; Montepeloso A; Dimartino A; Spadini S; Corre G; Patel J; Cavalca E; Ferro F; Gatti A; Milazzo R; Galy A; Politi LS; Rizzardi GP; Vallanti G; Poletti V; Biffi A
    Mol Ther; 2024 Mar; 32(3):619-636. PubMed ID: 38310355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of an immunodeficient mouse model of mucopolysaccharidosis type II.
    Smith MC; Belur LR; Karlen AD; Podetz-Pedersen K; Erlanson O; Laoharawee K; Furcich J; Lund TC; You Y; Seelig D; Webber BR; McIvor RS
    Mol Genet Metab; 2023 Apr; 138(4):107539. PubMed ID: 37023503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of genistein and coenzyme Q10 in oxidative damage and mitochondrial membrane potential in an attenuated type II mucopolysaccharidosis cellular model.
    Delgado CA; Poletto E; Vera LNP; Jacques CED; Vianna P; Reinhardt LS; Baldo G; Vargas CR
    Cell Biochem Funct; 2024 Mar; 42(2):e3932. PubMed ID: 38332678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive and adaptive behaviors associated with disease severity and genotype in patients with mucopolysaccharidosis II.
    Yee KS; Alexanderian D; Merberg D; Natarajan M; Wang S; Wu Y; Whiteman DAH
    Mol Genet Metab; 2023 Nov; 140(3):107652. PubMed ID: 37506513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurologic Recovery in MPS I and MPS II Mice by AAV9-Mediated Gene Transfer to the CNS After the Development of Cognitive Dysfunction.
    Podetz-Pedersen KM; Laoharawee K; Singh S; Nguyen TT; Smith MC; Temme A; Kozarsky K; McIvor RS; Belur LR
    Hum Gene Ther; 2023 Jan; 34(1-2):8-18. PubMed ID: 36541357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of iduronic acid biosynthesis by ebselen reduces glycosaminoglycan accumulation in mucopolysaccharidosis type I fibroblasts.
    Maccarana M; Tykesson E; Pera EM; Gouignard N; Fang J; Malmström A; Ghiselli G; Li JP
    Glycobiology; 2021 Nov; 31(10):1319-1329. PubMed ID: 34192316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucopolysaccharidosis type II zebrafish model exhibits early impaired proteasomal-mediated degradation of the axon guidance receptor Dcc.
    Manzoli R; Badenetti L; Bruzzone M; Macario MC; Rubin M; Dal Maschio M; Roveri A; Moro E
    Cell Death Dis; 2024 Apr; 15(4):269. PubMed ID: 38627369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced osteoblastic differentiation of parietal bone in a novel murine model of mucopolysaccharidosis type II.
    Yamazaki N; Ohira M; Takada S; Ohtake A; Onodera M; Nakanishi M; Okuyama T; Mashima R
    Mol Genet Metab Rep; 2023 Dec; 37():101021. PubMed ID: 38053930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of the novel
    Ngiwsara L; Rojnueangnit K; Wattanasirichaigoon D; Tim-Aroon T; Sawangareetrakul P; Champattanachai V; Ketudat-Cairns JR; Svasti J
    Exp Ther Med; 2017 Jun; 13(6):2989-2996. PubMed ID: 28588666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of iduronate-2-sulfatase gene variants detected in newborn screening for mucopolysaccharidosis type II in Japan.
    Hattori Y; Sawada T; Kido J; Sugawara K; Yoshida S; Matsumoto S; Inoue T; Hirose S; Nakamura K
    Mol Genet Metab Rep; 2023 Dec; 37():101003. PubMed ID: 38053932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mature neurons from iPSCs unveil neurodegeneration-related pathways in mucopolysaccharidosis type II: GSK-3β inhibition for therapeutic potential.
    Chen TY; Lin SP; Huang DF; Huang HS; Tsai FC; Lee LJ; Lin HY; Huang HP
    Cell Death Dis; 2024 Apr; 15(4):302. PubMed ID: 38684682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tagged IDS causes efficient and engraftment-independent prevention of brain pathology during lentiviral gene therapy for Mucopolysaccharidosis type II.
    Catalano F; Vlaar EC; Katsavelis D; Dammou Z; Huizer TF; van den Bosch JC; Hoogeveen-Westerveld M; van den Hout HJMP; Oussoren E; Ruijter GJG; Schaaf G; Pike-Overzet K; Staal FJT; van der Ploeg AT; Pijnappel WWMP
    Mol Ther Methods Clin Dev; 2023 Dec; 31():101149. PubMed ID: 38033460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disturbances in mitochondrial bioenergetics and control quality and unbalanced redox homeostasis in the liver of a mouse model of mucopolysaccharidosis type II.
    Pinheiro CV; Ribeiro RT; Roginski AC; Brondani M; Zemniaçak ÂB; Hoffmann CIH; Amaral AU; Wajner M; Baldo G; Leipnitz G
    Mol Cell Biochem; 2024 Mar; ():. PubMed ID: 38498105
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.